Morpheos Innovation

Strategic Consulting for Biotech & AI Commercialization

Empowering Innovation

Strategic partnering and business development initiatives for startups, investors, non-profits, and academia

Approach

Defining and Communicating Breakthroughs to Reach Investors & Customers: Innovative scientists and engineers hold extensive knowledge in their field, but information overload can lead to confused and disinterested customers and investors. At Morpheos, it's our job to help you efficiently & effectively communicate the value of your technology in order to capture your audience's attention and bring them onboard with your vision.

Responsive Image

At Morpheos, we work with scientists, engineers, and technical founders to translate complex innovations into clear, compelling messaging and clearly defined commercial strategy that resonates with investors, partners, and customers.

The process starts with deep listening — we directly engage with the technical team to understand the depth of the technology and fully grasp and define the technology's unique value proposition. We then work to refine and distill that complexity into a clear and efficient narrative that can (1) unify the development team around common goals, (2) draw in customers, and (3) efficiently capture the attention of investors and potential business partners.

Responsive Image

Services

Responsive Image

Morpheos offers comprehensive consulting services for startups, investors, and university tech transfer officers working with biotechnology and artificial intelligence (AI) technology platforms. Schedule a free 20 minute consultation call to discuss your organization's needs and brainstorm strategic initiatives.

Scientific Due Diligence & Commercialization Analysis

Business Development

Responsive Image

AI Productivity Coaching for Professionals & Executives

About

Brandon Hogstad, Ph.D., is principal consultant and founder of Morpheos Innovation LLC, where he partners with startups, investors, and academic institutions across biotech and AI-driven platforms. He specializes in strategic commercialization, alliance management, and scientific due diligence—guiding breakthrough innovations from concept to market.

Before launching Morpheos, Brandon led drug discovery accelerator programs and high-impact collaborations at NYU Langone Health, securing partnerships with global industry leaders like Sanofi and Pfizer (including the antiviral research that contributed to Paxlovid). He later advanced AI-driven immunotherapy initiatives at Immunai, forging strategic relationships to harness single-cell genomics for precision medicine.

Brandon earned his Ph.D. in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai. His contributions have appeared in top-tier journals such as Nature and the Journal of Experimental Medicine. Drawing on his broad expertise in target validation, preclinical strategy, and cutting-edge AI applications, Brandon remains committed to advancing medical science and global health through technology-driven innovation.